News

  • Final exhibition stands remaining for WHX Dubai 2026

    The Association of British HealthTech Industries (ABHI) has announced that only a handful of exhibition stands remain for WHX Dubai 2026, taking place 9–12 February at Dubai Exhibition Centre, Expo City Dubai. The 2025 edition attracted more than 70,000 attendees from 180 countries, bringing together an audience that included senior hospital practitioners, healthcare executives, manufacturers [...]

  • Merck’s cancer immunotherapy Keytruda shows breakthrough results in resistant ovarian cancer

    Merck’s immunotherapy drug Keytruda (pembrolizumab) has shown a "statistically significant" survival benefit in platinum-resistant ovarian cancer, potentially offering a new treatment path for patients with few options. In the phase 3 Keynote-B96 trial, the checkpoint inhibitor—used in combination with chemotherapy, with or without Avastin—led to improvements in progression-free survival compared to placebo and chemotherapy alone. [...]

  • ‘Concerning’ lack of female-only medical trials in UK, say health experts

    British medical experts are raising concerns about the underrepresentation of women in clinical studies, The Guardian reports, with male-only trials outnumbering female-focused research by 67 per cent. Healthcare professionals say they often have to make treatment decisions without enough sex-specific evidence, according to The Guardian’s analysis of comprehensive research data. A joint investigation by the Medicines and Healthcare [...]

  • AutoIVF secures investment to transform fertility care with automated egg retrieval system

    Fertility tech company AutoIVF has secured new equity funding in a round led by Vitrolife Group, with support from Alpha Edison and IVF specialists. The company’s lead product, OvaReady, automates egg retrieval and preparation, aiming to shift parts of the IVF process outside traditional lab settings. With infertility affecting one in six people worldwide, according [...]

  • Menopause research reveals critical gaps between women and healthcare providers

    New survey results highlight a striking disconnect between women and healthcare professionals when it comes to menopause, with many women enduring symptoms in silence. Findings from a poll of around 1,000 American women aged 40–70 show that one in three never discuss menopause symptoms with a healthcare provider, pointing to deep communication barriers. The research—commissioned [...]

  • Tech exec launches programme to address women’s leadership gap in technology sector

    A new 12-week executive programme aimed at tackling burnout and stalled career growth among senior women in technology will launch next month, amid ongoing concerns about gender representation in the industry. Padmasini Dayananda, a tech executive with 24 years’ experience, created the initiative to support women leaders in reshaping their careers and raising their profiles [...]

  • European healthcare professionals react to new ultrasound technology

    European ultrasound specialists have responded to the launch of an advanced ultrasound system by international health technology provider Mindray. The Resona A20, unveiled in Naples late last year at the 35th congress of the European Federation of Ultrasound Societies in Medicine and Biology, was developed by Mindray to allow healthcare professionals to have a “deeper [...]

  • Guidea acquired by Invene to expand AI healthcare capabilities

    Healthcare-focused engineering and AI solutions company Invene has acquired Guidea - a product design consultancy. The acquisition will expand Invene's capabilities beyond software engineering to expand into a full-stack innovation partner, supporting the next generation of AI-driven healthcare products from blueprint to build. The acquisition will see Guidea  - which launched Femovate as a women's [...]

  • New approach to treating aggressive breast cancers shows significant improvement in survival

    A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers. In a trial where cancers were treated with chemotherapy followed by a targeted cancer drug before surgery, 100 per cent of patients survived the critical three-year period post-surgery. The discovery could become the most effective treatment [...]

  • Three femtech companies shortlisted for award

    Three innovative companies have been shortlisted for a Femtech World Award. Now in its second year, the Femtech World Awards celebrate some of the best examples of leadership, innovation and impact in key areas that affect women's health and wellbeing. The Company of the Year award recognises an outstanding organisation that has demonstrated exceptional innovation, [...]